Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roden

Showing results (421-430 of 1,010) with videos related to

Pageof 101
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|October 23, 2016
Circulating adiponectin concentration is inversely associated with glucose tolerance and insulin secretion in people with newly diagnosed diabetesK S Weber, K Strassburger, G Pacini, et al.
Pharmacology & Therapeutics|April 27, 2018
Anticancer drug-induced cardiac rhythm disorders: Current knowledge and basic underlying mechanismsJoachim Alexandre, Javid J Moslehi, Kevin R Bersell, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 1, 1991
Molecular cloning and characterization of two voltage-gated K+ channel cDNAs from human ventricleM M Tamkun, K M Knoth, J A Walbridge, et al.
JAMA Network Open|March 20, 2023
Daily Step Counts Before and After the COVID-19 Pandemic Among All of Us Research ParticipantsStacy Desine, Hiral Master, Jeffrey Annis, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1984
Influence of genetic polymorphism on the metabolism and disposition of encainide in manT Wang, D M Roden, H T Wolfenden, et al.
Circulation|June 22, 1999
Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channelJ Wei, D W Wang, M Alings, et al.
European Heart Journal|August 5, 2000
Congenital and acquired long QT syndromeA J Camm, M J Janse, D M Roden, et al.
Clinical Pharmacology and Therapeutics|July 1, 1993
Immediate- versus controlled-release disopyramide: importance of saturable bindingR F Davies, L A Siddoway, L Shaw, et al.
The American Journal of Cardiology|January 15, 1992
Pharmacology of the class III antiarrhythmic agent sematilide in patients with arrhythmiasW Wong, H N Pavlou, U M Birgersdotter, et al.
The American Journal of Cardiology|November 15, 1985
Spectrum of antiarrhythmic response to encainideH J Duff, D M Roden, E L Carey, et al.
Pageof 101

Showing results (421-430 of 1,010) with videos related to

Sort By:
Pageof 101
Diabetic Medicine : a Journal of the British Diabetic Association|October 23, 2016
Circulating adiponectin concentration is inversely associated with glucose tolerance and insulin secretion in people with newly diagnosed diabetesK S Weber, K Strassburger, G Pacini, et al.
Pharmacology & Therapeutics|April 27, 2018
Anticancer drug-induced cardiac rhythm disorders: Current knowledge and basic underlying mechanismsJoachim Alexandre, Javid J Moslehi, Kevin R Bersell, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 1, 1991
Molecular cloning and characterization of two voltage-gated K+ channel cDNAs from human ventricleM M Tamkun, K M Knoth, J A Walbridge, et al.
JAMA Network Open|March 20, 2023
Daily Step Counts Before and After the COVID-19 Pandemic Among All of Us Research ParticipantsStacy Desine, Hiral Master, Jeffrey Annis, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1984
Influence of genetic polymorphism on the metabolism and disposition of encainide in manT Wang, D M Roden, H T Wolfenden, et al.
Circulation|June 22, 1999
Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channelJ Wei, D W Wang, M Alings, et al.
European Heart Journal|August 5, 2000
Congenital and acquired long QT syndromeA J Camm, M J Janse, D M Roden, et al.
Clinical Pharmacology and Therapeutics|July 1, 1993
Immediate- versus controlled-release disopyramide: importance of saturable bindingR F Davies, L A Siddoway, L Shaw, et al.
The American Journal of Cardiology|January 15, 1992
Pharmacology of the class III antiarrhythmic agent sematilide in patients with arrhythmiasW Wong, H N Pavlou, U M Birgersdotter, et al.
The American Journal of Cardiology|November 15, 1985
Spectrum of antiarrhythmic response to encainideH J Duff, D M Roden, E L Carey, et al.
Pageof 101